Newron Pharmaceuticals Says Phase II Study Show Painkiller Ralfinamide Improves Quality of Life
ZURICH (Thomson Financial) - Newron Pharmaceuticals SpA said its painkiller ralfinamide improved patients' quality of life compared to a placebo in phase II clinical tests.